QC
ZYME icon

Quadrature Capital’s Zymeworks ZYME Stock Holding History

Quadrature Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Sell
16,735
-6,282
-27% -$149K 0.01% 855
2025
Q4 		$606K Buy
+23,017
New +$502K 0.01% 649

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quadrature Capital's ZYME Position: Q1 2026 in Review

Quadrature Capital reduced its Zymeworks (ZYME) stake by 27% in Q1 2026, selling an estimated $149K and leaving 16,735 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #855.

Quadrature Capital first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. The position peaked at $606K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Quadrature Capital held 16,735 shares of Zymeworks worth $419K as of Q1 2026.
  • Quadrature Capital sold 6,282 Zymeworks shares in Q1 2026, an estimated $149K.
  • Zymeworks made up 0.01% of Quadrature Capital's portfolio in Q1 2026, its #855 holding.
  • Quadrature Capital first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
  • Quadrature Capital's Zymeworks position peaked at $606K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.